McKesson (NYSE:MCK) Issues FY25 Earnings Guidance

McKesson (NYSE:MCK) updated its FY25 earnings guidance on Tuesday. The company provided EPS guidance of $31.25-$32.05 for the period, compared to the consensus EPS estimate of $31.09. The company issued revenue guidance of $355.35-$361.53 billion, compared to the consensus revenue estimate of $341.05 billion.

Analyst Ratings Changes

A number of equities analysts recently commented on the stock. Citigroup raised their price objective on shares of McKesson from $575.00 to $620.00 and gave the stock a buy rating in a research note on Tuesday, April 30th. Evercore ISI raised their price objective on shares of McKesson from $590.00 to $600.00 and gave the stock an outperform rating in a research note on Wednesday. Leerink Partnrs reissued an outperform rating on shares of McKesson in a research note on Monday, February 26th. Deutsche Bank Aktiengesellschaft decreased their target price on shares of McKesson from $547.00 to $545.00 and set a buy rating for the company in a research note on Thursday. Finally, SVB Leerink assumed coverage on shares of McKesson in a research note on Monday, February 26th. They set an outperform rating and a $600.00 target price for the company. Two investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of Moderate Buy and a consensus target price of $571.47.

McKesson Stock Performance

Shares of NYSE MCK traded up $4.50 during trading on Friday, reaching $559.62. The company had a trading volume of 147,973 shares, compared to its average volume of 709,796. McKesson has a 52 week low of $373.28 and a 52 week high of $566.01. The stock has a market cap of $73.54 billion, a PE ratio of 24.80, a PEG ratio of 1.41 and a beta of 0.45. The business’s 50 day moving average price is $531.56 and its 200-day moving average price is $494.15.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $6.18 earnings per share for the quarter, missing analysts’ consensus estimates of $6.34 by ($0.16). The business had revenue of $76.36 billion for the quarter, compared to the consensus estimate of $79.32 billion. McKesson had a negative return on equity of 262.63% and a net margin of 0.99%. The company’s quarterly revenue was up 10.8% on a year-over-year basis. During the same period last year, the firm earned $7.19 earnings per share. Equities analysts anticipate that McKesson will post 27.59 earnings per share for the current year.

McKesson Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, July 1st. Stockholders of record on Monday, June 3rd will be issued a $0.62 dividend. This represents a $2.48 annualized dividend and a dividend yield of 0.44%. The ex-dividend date of this dividend is Friday, May 31st. McKesson’s dividend payout ratio (DPR) is presently 11.08%.

Insider Activity

In related news, CEO Brian S. Tyler sold 3,473 shares of the stock in a transaction on Friday, March 15th. The shares were sold at an average price of $524.55, for a total transaction of $1,821,762.15. Following the completion of the transaction, the chief executive officer now owns 43,445 shares in the company, valued at $22,789,074.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, EVP Leann B. Smith sold 186 shares of the firm’s stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $496.00, for a total transaction of $92,256.00. Following the transaction, the executive vice president now directly owns 1,511 shares of the company’s stock, valued at $749,456. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Brian S. Tyler sold 3,473 shares of the firm’s stock in a transaction dated Friday, March 15th. The stock was sold at an average price of $524.55, for a total transaction of $1,821,762.15. Following the transaction, the chief executive officer now directly owns 43,445 shares in the company, valued at $22,789,074.75. The disclosure for this sale can be found here. Corporate insiders own 0.21% of the company’s stock.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.